跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
應用zebularine治療大腸直腸癌：以缺氧誘導分子(HIF-1α)為標靶(1-2)
Yang, Pei-Ming
(PI)
癌症生物學與藥物研發博士學位學程
研究計畫
:
A - 政府部門
›
b - 國家科學及技術委員會
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Carcinoma
100%
Zebularine
100%
Hypoxia
54%
Autophagy
36%
Unfolded Protein Response
18%
Anticarcinogen
18%
Cell Death
18%
AMP-Activated Protein Kinase
18%
Drug Resistance
18%
Programmed Cell Death
9%
Reticulophagy
9%
DNA Methyltransferase Inhibitor
9%
Colon Carcinoma
9%
Anoxia
9%
Endoplasmic Reticulum Stress
9%
Cancer Cell
9%
In Vitro
9%
Solid Malignant Neoplasm
9%
Malignant Neoplasm
9%
Physiological Process
9%
Cancer Treatment
9%
Colitis
9%
Cytoprotective Agent
9%
Hypoxia Inducible Factor
9%
Starvation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Zebularine
100%
Hypoxia
54%
Anticarcinogen
18%
Drug Resistance
18%
Malignant Neoplasm
18%
Colon Carcinoma
9%
DNA Methyltransferase Inhibitor
9%
Colitis
9%
Cytoprotective Agent
9%
Anoxia
9%
Solid Malignant Neoplasm
9%
Hypoxia Inducible Factor
9%
Biochemistry, Genetics and Molecular Biology
Zebularine
100%
Anticancer
45%
Autophagy
36%
Unfolded Protein Response
18%
AMP-activated Protein Kinase
18%
Drug Resistance
18%
Cell Death
18%
Molecular Mechanism
18%
Physiological Process
9%
Hypoxia-Inducible Factors
9%
Cancer Cell
9%
Reticulophagy
9%
Colon
9%
Endoplasmic Reticulum Stress
9%
DNA Methyltransferase
9%
Programmed Cell Death
9%
Alternative Energy
9%